Author:
Bandelow B.,Müller P.,Frick U.,Gaebel W.,Linden M.,Müller-Spahn F.,Pietzcker A.,Tegeler J.,
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,General Medicine
Reference19 articles.
1. Bandelow B, Müller P, Gaebel W, Köpcke W, Linden M, Müller-Spahn F, Pietzcker A, Reischies FM, Tegeler J (1990) Depressive syndromes in schizophrenic patients after discharge from hospital. Eur Arch Psychiatry Clin Neurosci 240:113–120
2. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The Global Assessment Scale (1976) A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33:766–771
3. Heinrich K (1960) Die gezielte Symptomprovokation mit monoaminooxidasehemmenden Substanzen in Diagnostik und Therapie schizophrener Psychosen. Nervenarzt 31:507
4. Helmchen H, Hippius H (1967) Depressive Syndrome im Verlauf neuroleptischer Therapie. Nervenarzt 38(10):455–458
5. Hogarty GE, Munetz MR (1984) Pharmacogenic depression among outpatient schizophrenic patients: a failure to substantiate. J. Clin Pharmacol 4:17–24
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Perphenazine for schizophrenia;Cochrane Database of Systematic Reviews;2015-03-06
2. Intermittent drug techniques for schizophrenia;Cochrane Database of Systematic Reviews;2013-07-20
3. Training to recognise the early signs of recurrence in schizophrenia;Cochrane Database of Systematic Reviews;2013-02-28
4. Antipsychotic medication for early episode schizophrenia;Cochrane Database of Systematic Reviews;2011-06-15
5. Predictors of suicide in psychiatric hospital;Acta Psychiatrica Scandinavica;2007-11-13